STOCK TITAN
  1. Home
  2. Sec-filings
  3. TARA
  4. [SCHEDULE 13G] Protara Therapeutics, Inc. SEC Filing

[SCHEDULE 13G] Protara Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock TARA logo
Protara Therapeutics Inc

NASDAQ:TARA

TARA Rankings

#4440 Ranked by Market Cap
N/A Ranked by Dividends

TARA Latest News

Sep 2, 2025
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 27, 2025
Protara Therapeutics to Participate in Upcoming Investor Conferences
Aug 11, 2025
Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
Aug 1, 2025
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 1, 2025
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TARA Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] Protara Therapeutics, Inc. SEC Filing
Aug 14, 2025
[SCHEDULE 13G/A] Protara Therapeutics, Inc. SEC Filing
Aug 11, 2025
[S-8] Protara Therapeutics, Inc. Employee Benefit Plan Registration
Aug 11, 2025
[10-Q] Protara Therapeutics, Inc. Quarterly Earnings Report
Aug 11, 2025
[8-K] Protara Therapeutics, Inc. Reports Material Event

TARA Stock Data

165.52M
37.47M
2.79%
78.74%
7.74%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW YORK